A. Anti-hypertensives
B. Anti-diabetics
C. Anticoagulants
D. Anti-fibrinolytics
A. Range of disease in which the drug beneficial
B. Maximal intensity of response that can be produced by the drug
C. The therapeutic does range of the drug
D. The therapeutic index of the drug
A. It is the proportion (fraction) of unchanged drug that reaches the systemic circulation
B. Biovailability of an orally administered drug can be calculated by comparing the area under cure (o-a) after oral and intravenous (IV) administration
C. Low oral biovailability always and necessarily mean poor absorption
D. Biovailability can be determined from plasma concentration or urinary excretion data
A. Indifference
B. Synergy
C. Antagonism
D. Bacterial symbiosis
A. Amiodarone
B. Phenytoin
C. Verapamil
D. Disorpyamide
A. Physical dependence
B. Psychological dependence
C. Addiction
D. Habituation
A. Genetic component
B. Psychological component
C. Psysiological component
D. Nutritional component
A. Phenytoin
B. Phenabarbtion
C. Erythromycin
D. Digoxin
A. Are more common than first order kinetics
B. Decrease in concentration exponentially with time
C. Have a half – life independent of dose
D. Show a plot of drug concentration versus time that is linear
A. LD 100/Ed100
B. ED 100/LD 100
C. LD 50/ED500
D. ED50/LD50